John P. Clark
Comptroller/Controller/Auditor presso IMMUNE PHARMACEUTICALS, INC.
Posizioni attive di John P. Clark
Società | Posizione | Inizio | Fine |
---|---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 20/11/2017 | - |
Segretario Aziendale | 20/11/2017 | - |
Storia della carriera di John P. Clark
Precedenti posizioni note di John P. Clark
Società | Posizione | Inizio | Fine |
---|---|---|---|
KOGETO INC | Direttore Finanziario/CFO | 07/04/2014 | 01/08/2015 |
Formazione di John P. Clark
Montclair State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Comptroller/Controller/Auditor | 1 |
Settori
Consumer Durables | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Kogeto, Inc.
Kogeto, Inc. Electronics/AppliancesConsumer Durables Kogeto, Inc. provided interactive and panoramic video capturing services. The company was founded by Jeff D. Glasse on January 10, 2014 and headquartered in New York, NY. | Consumer Durables |
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
- Borsa valori
- Insiders
- John P. Clark
- Esperienza